Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Weiser

Showing results (1-10 of 176) with videos related to

Pageof 18
Sort By:
The American Journal of Psychiatry|August 5, 2011
Early intervention for schizophrenia: the risk-benefit ratio of antipsychotic treatment in the prodromal phaseMark Weiser
Schizophrenia Bulletin|September 19, 2008
Using clinical data bases to study schizophreniaMark Weiser, Michael Davidson
CNS Spectrums|July 27, 2004
Prodromal schizophrenia: the dilemma of prediction and early interventionMichael Davidson, Mark Weiser
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 13, 2015
Quantifying motivational deficits and apathy: a review of the literatureMark Weiser, George Garibaldi
Dialogues in Clinical Neuroscience|August 3, 2005
Interpreting the association between cannabis use and increased risk for schizophreniaMark Weiser, Shlomo Noy
Molecular Psychiatry|July 10, 2021
Identifying an elusive target with the help of an unproven techniqueMark Weiser, Michael Davidson
The Lancet. Psychiatry|December 21, 2019
Insights into metabolic dysregulations associated with antipsychoticsYoav Domany, Mark Weiser
The Psychiatric Clinics of North America|March 30, 2013
Testosterone and mood in aging menStuart N Seidman, Mark Weiser
Schizophrenia Research|June 21, 2005
Comments on risk for schizophreniaMark Weiser, Michael Davidson, Shlomo Noy
The Lancet. Psychiatry|September 18, 2025
Running a psychiatric ward in times of warMark Weiser, Itai Pessach, Amitai Ziv
Pageof 18

Showing results (1-10 of 176) with videos related to

Sort By:
Pageof 18
The American Journal of Psychiatry|August 5, 2011
Early intervention for schizophrenia: the risk-benefit ratio of antipsychotic treatment in the prodromal phaseMark Weiser
Schizophrenia Bulletin|September 19, 2008
Using clinical data bases to study schizophreniaMark Weiser, Michael Davidson
CNS Spectrums|July 27, 2004
Prodromal schizophrenia: the dilemma of prediction and early interventionMichael Davidson, Mark Weiser
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 13, 2015
Quantifying motivational deficits and apathy: a review of the literatureMark Weiser, George Garibaldi
Dialogues in Clinical Neuroscience|August 3, 2005
Interpreting the association between cannabis use and increased risk for schizophreniaMark Weiser, Shlomo Noy
Molecular Psychiatry|July 10, 2021
Identifying an elusive target with the help of an unproven techniqueMark Weiser, Michael Davidson
The Lancet. Psychiatry|December 21, 2019
Insights into metabolic dysregulations associated with antipsychoticsYoav Domany, Mark Weiser
The Psychiatric Clinics of North America|March 30, 2013
Testosterone and mood in aging menStuart N Seidman, Mark Weiser
Schizophrenia Research|June 21, 2005
Comments on risk for schizophreniaMark Weiser, Michael Davidson, Shlomo Noy
The Lancet. Psychiatry|September 18, 2025
Running a psychiatric ward in times of warMark Weiser, Itai Pessach, Amitai Ziv
Pageof 18